For the first time, a government-funded UK trial will investigate psilocybin-assisted psychotherapy for targetting relapses associated with opioid addiction, aiming to bring an innovative new therapy to the NHS if successful. The post Landmark UK trial to investigate psilocybin for opioid addiction relapse appeared first on Psychedelic Health.
